arrow
D

Dennis Lund Hansen

Odense University Hospital
H指数:18
被引数:1,749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark

干扰素-α与羟基脲在骨髓增殖性肿瘤患者中的比较(DALIAH):一项在丹麦进行的为期3期的多中心、随机、开放标签临床试验

2026-09-010
OAAI
Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification

基于氟达拉滨的治疗可改善混合表型急性白血病的生存率:一项使用WHO 2022分类的人群研究

2026-04-170
OA
Epidemiology and characteristics of validated mixed phenotype acute leukaemia—A comprehensive nationwide Danish cohort study

流行病学和特征:经验证的混合表型急性白血病的全面全国性丹麦队列研究

2025-10-280
OAAI
A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 – Real-world outcomes and clinicopathological characteristics

一项关于RUNX1::RUNX1T1急性髓系白血病的丹麦全国性基于人群的队列研究——真实世界结局与临床病理特征

2025-10-210
OA
Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy

三体8在经强化疗治疗的急性髓系白血病患者中的结局及预后影响

2025-08-280
OAAI
DAHEAN: A Danish nationwide study ensuring quality assurance through real-world data for suspected hereditary anemia patients
2024-07-310
OAAI
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

钙网蛋白突变体骨髓增生性肿瘤诱导mhc-i偏斜,这可以通过优化的肽癌症疫苗来克服

2022-06-1512
PRE
Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses
2022-03-3031
OAAI
Evans syndrome in adults: an observational multicenter study

成人埃文斯综合征:一项多中心观察性研究

2021-12-1627
OAAI